NCT03712956 2023-09-21
CAELYX® as Adjuvant Treatment in Early Stage Luminal B Breast Cancer BREAST CANCER
European Institute of Oncology
Phase 2 Unknown
Clinical Trials
14 trialsNCT05386524 2023-02-16
Sintilimab and Bevacizumab Biosimilar Combined With PLD in mTNBC
Fudan University
Phase 2 Unknown
NCT05656079 2022-12-19
easy laugh
Shanghai Pudong Hospital
Phase NA Unknown
NCT05346107 2022-04-26
PLD-cyclophosphamide-Nab-P Continuously Combined With Dual HER2 Blockage for HER2-positive Breast Cancer
Xijing Hospital
Phase 2 Unknown
NCT05302336 2022-04-14
AC vs TC in Patients With HR-positive, HER2-negative Early Breast Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 4 Unknown
NCT05097248 2021-10-28
Camrelizumab in Combination With PLD and Losartan in Patients With TNBC Who Have Received ≦ 1 Line of Chemotherapy
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 2 Unknown
NCT03994107 2020-01-22
Pegylated Liposomal Doxorubicin Plus Albumin-Bound Paclitaxel and Trastuzumab in HER-2 Positive Breast Cancer
Peking Union Medical College
Phase 1/2 Unknown
NCT02953184 2017-12-29
Marched Pair Study Conventional Doxorubicin(DOX) Versus Pegylated Liposomal Doxorubicin(PLD) Neoadjuvant Chemotherapy
Jilin University
Phase 2 Unknown
NCT03359694 2017-12-02
Mutation Scores and Differential Protein Evaluating Efficacy in Adjuvant Chemotherapy in HER2(-) Luminal B Breast Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 3 Unknown
NCT00518583 2010-01-15
Phase II Study in Patients With Operable Breast Cancer
Aptium Oncology Research Network
Phase 2 Unknown
NCT00531973 2009-02-18
LITE
Catholic University, Italy
Phase 4 Unknown
NCT00159094 2008-06-02
A Trial of Doxil and Multiday Vinorelbine in Patients With Metastatic Breast Cancer
Hematology Oncology Consultants
Phase 2 Unknown
NCT00250874 2005-11-08
Myocet, Docetaxel & Trastuzumab as 1st Line Treatment of Patients With HER-2/Neu Positive Metastatic Breast Cancer
Zeneus Pharma
Phase 2 Unknown
NCT00006433 2005-06-24
Phase I/II Trial of Doxil and Hyperthermia for Breast Cancer Patients With Chest Wall Recurrence or Stage IV Disease With Locally Advanced Breast Cancer
National Center for Research Resources (NCRR)
Phase 2 Unknown